These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1360088)

  • 1. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.
    Sun XF; Carstensen JM; Zhang H; Stål O; Wingren S; Hatschek T; Nordenskjöld B
    Lancet; 1992 Dec; 340(8832):1369-73. PubMed ID: 1360088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas.
    Sun XF; Carstensen JM; Zhang H; Arbman G; Nordenskjöld B
    Eur J Cancer; 1996 Oct; 32A(11):1963-7. PubMed ID: 8943682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.
    Sun XF; Carstensen JM; Stål O; Zhang H; Nilsson E; Sjödahl R; Nordenskjöld B
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):443-8. PubMed ID: 8291217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
    Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
    J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
    Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
    Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis.
    Flamini G; Curigliano G; Ratto C; Astone A; Ferretti G; Nucera P; Sofo L; Sgambato A; Boninsegna A; Crucitti F; Cittadini A
    Eur J Cancer; 1996 May; 32A(5):802-6. PubMed ID: 9081357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma.
    Lazaris AC; Theodoropoulos GE; Anastassopoulos P; Nakopoulou L; Panoussopoulos D; Papadimitriou K
    Histol Histopathol; 1995 Jul; 10(3):661-8. PubMed ID: 7579815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
    Martín R; Nieto S; Santamaría L
    Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer.
    Zhang H; Sun XF
    Int J Oncol; 2001 Jul; 19(1):49-52. PubMed ID: 11408921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
    Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
    J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
    Zhang Hong
    Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.
    Buglioni S; D'Agnano I; Vasselli S; Perrone Donnorso R; D'Angelo C; Brenna A; Benevolo M; Cosimelli M; Zupi G; Mottolese M
    Am J Clin Pathol; 2001 Sep; 116(3):360-8. PubMed ID: 11554164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutation found to be a significant prognostic indicator in distal colorectal cancer.
    Okubo R; Masuda H; Nemoto N
    Oncol Rep; 2001; 8(3):509-14. PubMed ID: 11295071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
    Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
    Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
    Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
    Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.